✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Rubicon Research Ltd.

RUBICON

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹10,396 Cr.
P/E
77.37

Rubicon Research Ltd.

  • Rubicon Research
  • Sun Pharma Inds.
  • Aurobindo Pharma

FAQs on Rubicon Research Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Rubicon Research is 77.37

View FAQ's On Business

Growth Table

  • Rubicon Research Ltd.
  • Sun Pharma Inds.
  • Aurobindo Pharma

Balance Sheet

  • Rubicon Research Ltd.
  • Sun Pharma Inds.
  • Aurobindo Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Rubicon Research Ltd.
  • Sun Pharma Inds.
  • Aurobindo Pharma

Cash Flow

  • Rubicon Research Ltd.
  • Sun Pharma Inds.
  • Aurobindo Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Rubicon Research Ltd.
  • Sun Pharma Inds.
  • Aurobindo Pharma

Quarterly Results

  • Rubicon Research Ltd.
  • Sun Pharma Inds.
  • Aurobindo Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Rubicon Research Ltd. Financials

Balance sheet of Rubicon Research is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Rubicon Research is increasing.
Latest net debt of Rubicon Research is ₹365 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹161 Crs.

The profit is oscillating.
The profit of Rubicon Research is ₹88.33 Crs for TTM, ₹134 Crs for Mar 2025 and ₹91.01 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Rubicon Research latest dividend payout ratio is 0.02% and 3yr average dividend payout ratio is 0.03%

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech